OPTIMIZATION OF DOSIMETRIC PLANNING PARAMETERS FOR RADIOTHERAPY OF HEAD AND NECK TUMORS
The study was conducted at the Center of Nuclear Medicine and Oncology of the Abai Region (Semey, Kazakhstan) and was aimed at the quantitative evaluation and optimization of dose planning parameters in patients with head and neck tumors. A retrospective analysis included seven patients (N = 7) treated in 2024, for whom radiotherapy plans were generated using intensity-modulated radiation therapy (Intensity-Modulated Radiation Therapy, IMRT) and volumetric modulated arc therapy (Volumetric Modulated Arc Therapy, VMAT) on a TrueBeam linear accelerator within the Eclipse treatment planning system. The objective of the study was a comparative physical-dosimetric assessment of plan quality with analysis of key dosimetric metrics and logistical efficiency of dose delivery. The analysis demonstrated comparable coverage of the planning target volume (PTV) for both techniques, while clinically significant differences were observed in dose distribution to organs at risk. The use of VMAT resulted in a reduction of the mean dose to the parotid glands by 4,65 Gy compared with IMRT (19,60±7,97 Gy vs. 24,26±3,75 Gy), achieving values below the critical threshold of 25 Gy and contributing to preservation of glandular function. The mean dose to the spinal cord was also lower with VMAT (37,96±4,16 Gy vs. 41,37±1,94 Gy), thereby enhancing radiation safety of treatment. Logistical analysis revealed a clear advantage of VMAT, characterized by more than a 60% reduction in monitor units and dose delivery time compared with IMRT, which contributes to decreased radiation exposure of organs at risk and supports the feasibility of VMAT as a preferred technique in routine clinical practice.
Сведения
- Журнал
- NNC RK Bulletin
- Опубликовано
- 2026 · № 1, С. 177-186
- Язык
- Английский
- ISSN
- 1729-7516 · 1729-7885
- Издатель
- Republican State Enterprise "National Nuclear Center of the Republic of Kazakhstan
- Аффилиации
- “Center of Nuclear Medicine and Oncology” of Abay Regional Health Department